Patent · US Active

Compositions and methods for treating CEP290-associated disease

US11141493B2 · kind B2 · utility

1Cited by
26References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 2018
Grant dateOct 12, 2021
Priority date
Expiry dateAug 2, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treatment of CEP290 related diseases are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.